The 8-hour Buprenorphine Training - PART 1 - 6/10/2023-The Half and Half Course Agenda

The Half and Half Course Agenda

Pdf Summary

The document is an overview of the PCSS Half and Half Course on Office-Based Treatment for Opioid Use Disorders. The course is divided into two parts, with Part 1 consisting of 4.25 hours of content. The course covers various topics related to the treatment of opioid use disorder with buprenorphine/naloxone.<br /><br />The overview section provides a brief introduction to the course, while the patient evaluation section focuses on the process of assessing patients with opioid use disorder. The specialty topics section explores specific areas of interest within the field. A case study is included to provide a practical application of the concepts discussed.<br /><br />The clinical uses of buprenorphine are discussed in detail, including its indications and benefits. Another case study is presented to further illustrate the use of buprenorphine in a clinical setting. The importance of urine drug testing in monitoring patients is emphasized, with a case study to demonstrate its role.<br /><br />An overview of clinical tools is provided, highlighting the various resources available for healthcare professionals treating opioid use disorder. The course concludes with a question and answer session, allowing participants to clarify any doubts or questions they may have.<br /><br />Throughout the course, there are 10 interactive polling questions that randomly appear. While participants are not graded on these questions, they are required to answer them for participation credit. The purpose of these questions is to assess participants' understanding of the material and ensure their active engagement in the training.<br /><br />Overall, the PCSS Half and Half Course aims to enhance healthcare professionals' knowledge and skills in the treatment of opioid use disorder using buprenorphine/naloxone.

Keywords

PCSS Half and Half Course

Office-Based Treatment

Opioid Use Disorders

Buprenorphine/Naloxone

Patient Evaluation

Specialty Topics

Clinical Uses of Buprenorphine

Urine Drug Testing

Clinical Tools

Question and Answer Session